甲状腺转录因子-1阳性胸腺瘤与肺腺癌并存一例
本文报告一例63岁无症状男性,表现为右肺上叶结节和纵隔中部囊性肿瘤,手术切除右肺上叶及纵隔肿瘤后,组织学检查显示TTF-1阳性B2型胸腺瘤和浸润性肺腺癌。作者指出,尽管罕见,胸腺瘤应纳入TTF-1阳性肿瘤的鉴别诊断。
要点
- TTF-1阳性并非肺原发肿瘤独有,胸腺瘤也可表达。
- 同时发现肺结节与纵隔肿瘤时需考虑双原发可能。
- 手术切除标本的组织学检查对明确诊断至关重要。
核心结论
- TTF-1阳性胸腺瘤可与肺腺癌并存,胸腺瘤应纳入TTF-1阳性肿瘤的鉴别诊断。
研究设计与样本
- 个案报告:一例63岁无症状男性,行右肺上叶及纵隔肿瘤切除术。
主要发现
- 组织学检查显示TTF-1阳性B2型胸腺瘤和浸润性肺腺癌。
临床怎么用
- 对TTF-1阳性肿瘤应考虑到胸腺瘤可能,避免误诊为肺原发肿瘤。
局限性
- 仅为单例个案报告,证据级别有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thyroid transcription factor-1 (TTF-1) has been widely used as a marker of primary lung cancer. However, there have been few reports on TTF-1 expression in thymomas. We here report the case of an asymptomatic 63-year-old man who presented with a right upper lung nodule and cystic mid-mediastinal tumor. The right upper lobe of the lung and the mediastinal tumor were resected. Histological examination of the operative specimen revealed TTF-1-positive type B2 thymoma and invasive pulmonary adenocarcinoma. Although rare, thymoma should be included in the different diagnosis of TTF-1-positive tumors.
引用
- Kataoka Y, Fujita T, Hanaoka J, et al. Coincidence of Thyroid Transcription Factor-1-Positive Thymoma and Pulmonary Adenocarcinoma. Ann Thorac Surg. 2021. PMID: 34624262. doi:10.1016/j.athoracsur.2021.08.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。